Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase NA 1Phase EARLY_PHASE1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Weight Loss 1Colorectal Adenocarcinoma 1Cachexia 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Fluoxetine × Clear all
NCT06225011 2026-05-11

Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer

Jonsson Comprehensive Cancer Center

Phase 1 Recruiting
10 enrolled
Gastrointestinal

Colorectal Adenocarcinoma

NCT00489593 2015-01-08

Olanzapine in Patients With Advanced Cancer and Weight Loss

M.D. Anderson Cancer Center

Phase 1 Completed
57 enrolled

Cachexia, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡